Answers are grounded in this paper and cite their sources.
bacteremia. Ceftazidime-avibactam treatment led to emergence of resistance, and alternative combination therapy failed due to persistent infection and toxicity. The infection resolved after initiation of meropenem-vaborbactam, which created a bridge to retransplantation. Treatment-emergent ceftazidime-avibactam resistance is increasingly recognized, suggesting a role for meropenem-vaborbactam.
No takes yet. Share an insight, caveat, or question.
Athans et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: